CTOs on the Move

Greer Margolis Mitchell Burns and Associates

www.gmmb.com

 
Greer Margolis Mitchell Burns and Associates is one of the leading companies in Business Services industry. Greer Margolis Mitchell Burns and Associates is based in Washington, DC. You can find more information on Greer Margolis Mitchell Burns and Associates at www.gmmb.com
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.gmmb.com
  • 3050 K St NW Suite 100
    Washington, DC USA 20007
  • Phone: 202.338.8700

Executives

Name Title Contact Details

Similar Companies

Factory Direct Marine & RV

Factory Direct Marine & RV sales, parts, and service. THE place to find your dream bowrider, center console, pontoon, travel trailer, fifth wheel, or motorhome.

Olsondenali

Olsondenali is a Minneapolis, MN-based company in the Business Services sector.

AGBU

The Armenian General Benevolent Union is a non-profit Armenian organization established in Cairo, Egypt, in 1906.

360 Graphics

360 Graphics is a New York, NY-based company in the Business Services sector.

Applied BioCode, Inc.

Applied BioCode focuses on research and development, manufacturing, and commercialization of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications. The HQ of the company is at Los Angles, California. The company develops, manufactures, and commercializes multiplex diagnostic testing products. Applied BioCode, Inc. has combined "digital barcodes" with immunochemistry and molecular probes to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The microscale BMB, with a diameter of human hair, is tagged with immunochemistry or molecular probes, allowing the digital barcode to be easily scanned and accurately identified for a very high number (4,096 barcodes) of biological targets with no ambiguity. Applied BioCode, Inc. products focus on the $4.5 billion molecular diagnostic infectious disease segment of the market with assays that detect pathogens for gastrointestinal infections, respiratory infections and other high value diseases. The company has currently received FDA Clearance for the BioCode® MDx-3000 system with a 17-plex Gastrointestinal Pathogen Panel (GPP) and a 17-plex Respiratory Pathogen Panel (RPP). The Gastrointestinal Pathogen Panel (GPP) has also obtained the CE-Mark for use in European countries conforming to CE-Mark regulations. In the face of the COVID-19 pandemic, Applied BioCode, Inc. also manufactures a BioCode® SARS-CoV-2 Assay, authorized by the FDA under the Emergency Use Authorization (EUA). Applied BioCode, Inc. also partners with a variety of diagnostic and pharmaceutical companies with applications that include the infectious disease, autoimmune disease, allergy, gut microbiome, and veterinary diagnostics.